Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Annexon, Inc.ANNX · Entity 5011 | EVP & CHIEF INNOVATION OFFICER | June 11, 2026 | June 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Annexon, Inc.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 184,807 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Exercise / conversion · Acquired 30,646 · Balance 184,807 |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.85 · Expires 2026-08-11 | Direct | 0 |
Reported balance
After 2026-06-11 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-06-11 · Exercise / conversion · Disposed 30,646 · Balance 0 F1: The shares subject to the option are fully vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares subject to the option are fully vested and exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 15, 2026 20:15 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,646 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001818525-26-000004 · form4-06152026_040601.xml · derivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,646 shares Expires 2026-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| June 11, 2026 Filed Jun 15, 2026 20:15 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 30,646 | $1.85 | $56,698.16 |
DisclosureSEC source: 0001818525-26-000004 · form4-06152026_040601.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 184,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 21:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,566 | $5.42 | $30,167.72 |
DisclosureSEC source: 0001818525-26-000003 · form4-03042026_040338.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,161 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $5.35 to $5.57, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 00:05 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 250,000 | $0.00 Strike: $5.10 | $0.00 |
DisclosureSEC source: 0001818525-26-000002 · form4-02242026_120245.xml · derivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2036-02-19 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date. Read SEC document |
| February 19, 2026 Filed Feb 24, 2026 00:05 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 62,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001818525-26-000002 · form4-02242026_120245.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 159,727 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 19 of each year, with the first 1/3rd vesting on February 19, 2027, subject to Reporting Person's continuous service with the Issuer as of each such vesting date. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 7,857 | $5.11 | $40,149.27 |
DisclosureSEC source: 0001818525-26-000001 · form4-02202026_040207.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,227 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $4.925 to $5.17, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| July 14, 2025 Filed Jul 16, 2025 20:20 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,116 | $2.58 | $2,879.28 |
DisclosureSEC source: 0001415889-25-019838 · form4-07162025_040706.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,084 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $2.57 to $2.64, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 27, 2025 Filed Mar 3, 2025 21:48 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 272,575 | $0.00 Strike: $2.50 | $0.00 |
DisclosureSEC source: 0001415889-25-006191 · form4-03032025_090340.xml · derivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,575 Underlying: Common Stock · 272,575 shares Expires 2034-02-27 F2 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 27, 2025 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:51 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 8,345 | $2.91 | $24,283.95 |
DisclosureSEC source: 0001415889-25-004888 · form4-02202025_090206.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,237 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $2.77 to $3.1376, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 21:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,783 | $2.99 | $5,331.17 |
DisclosureSEC source: 0001415889-25-004432 · form4-02182025_040203.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,582 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $2.895 to $3.0297, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 21:09 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,408 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001415889-24-025382 · form4-10172024_091004.xml · derivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,646 Underlying: Common Stock · 5,408 shares Expires 2026-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares subject to the option are fully vested and exercisable. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 21:09 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,408 | $7.41 | $40,073.28 |
DisclosureSEC source: 0001415889-24-025382 · form4-10172024_091004.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,365 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 21:09 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 5,408 | $1.85 | $10,005.34 |
DisclosureSEC source: 0001415889-24-025382 · form4-10172024_091004.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,773 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 19, 2024 Filed Sep 20, 2024 20:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 4,500 | $7.10 | $31,950.00 |
DisclosureSEC source: 0001415889-24-023771 · form4-09202024_040902.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024. Read SEC document |
| September 12, 2024 Filed Sep 16, 2024 20:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,500 | $6.16 | $33,880.00 |
DisclosureSEC source: 0001415889-24-023441 · form4-09162024_040901.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 4,500 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024. Read SEC document |
| September 05, 2024 Filed Sep 6, 2024 20:30 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,500 | $5.64 | $31,020.00 |
DisclosureSEC source: 0001415889-24-023018 · form4-09062024_040902.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 10,000 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024. Read SEC document |
| August 29, 2024 Filed Aug 30, 2024 22:00 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,500 | $5.95 | $32,725.00 |
DisclosureSEC source: 0001415889-24-022645 · form4-08302024_100809.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: Plan reported Ownership: Indirect · By Spouse Disclosed balance after: 15,500 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:46 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,106 | $6.02 | $6,658.12 |
DisclosureSEC source: 0001415889-24-019677 · form4-07172024_080745.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,365 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $5.97 to $6.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 27, 2024 Filed Mar 3, 2025 21:48 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 44,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-006191 · form4-03032025_090340.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,200 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 27 of each year, with the first 1/3rd vesting on February 27, 2026. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:31 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 2,604 | $5.51 | $14,348.04 |
DisclosureSEC source: 0001415889-24-004625 · form4-02212024_040217.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,471 F2 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of RSUs. F3 · price: This transaction was executed in multiple trades in prices ranging from $5.34 to $5.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:31 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $5.13 | $0.00 |
DisclosureSEC source: 0001415889-24-004625 · form4-02212024_040217.xml · derivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2034-02-16 F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 16, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:31 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantCommon Stock | 39,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-004625 · form4-02212024_040217.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,075 F1 · shares: Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 16 of each year, with the first 1/3rd vesting on February 16, 2025. Read SEC document |
| February 12, 2024 Filed Feb 15, 2024 00:52 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,810 | $5.54 | $10,027.40 |
DisclosureSEC source: 0001415889-24-003854 · form4-02152024_120219.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & CHIEF INNOVATION OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,075 F1 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F2 · price: This transaction was executed in multiple trades in prices ranging from $5.33 to $5.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F3 · balance_after: Includes 29,392 RSUs. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:12 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,385 | $0.00 Strike: $1.85 | $0.00 |
DisclosureSEC source: 0001209191-23-059988 · doc4.xml · derivative · entry 5 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 10,385 shares Expires 2026-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:12 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,615 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001209191-23-059988 · doc4.xml · derivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,615 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:12 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 21,000 | $4.52 | $94,966.20 |
DisclosureSEC source: 0001209191-23-059988 · doc4.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. F2 · price: This transaction was executed in multiple trades in prices ranging from $4.50 to $4.58, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:12 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 10,385 | $1.85 | $19,213.29 |
DisclosureSEC source: 0001209191-23-059988 · doc4.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. Read SEC document |
| December 27, 2023 Filed Dec 29, 2023 21:12 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 10,615 | $1.41 | $14,962.90 |
DisclosureSEC source: 0001209191-23-059988 · doc4.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. Read SEC document |
| December 27, 2023 Filed Jan 23, 2024 22:00 UTC Amendment | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 21,000 | $4.52 | $94,966.20 |
DisclosureSEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,885 F5 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. F3 · price: This transaction was executed in multiple trades in prices ranging from $3.72 to $3.90, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F4 · balance_after: Includes 33,559 restricted stock units. F6 · balance_after: Column 5 is being amended to reflect the correct amount of securities beneficially owned following reported transaction. Read SEC document |
| December 27, 2023 Filed Jan 23, 2024 22:00 UTC Amendment | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 10,385 | $1.85 | $19,213.29 |
DisclosureSEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. F4 · balance_after: Includes 33,559 restricted stock units. F6 · balance_after: Column 5 is being amended to reflect the correct amount of securities beneficially owned following reported transaction. Read SEC document |
| December 27, 2023 Filed Jan 23, 2024 22:00 UTC Amendment | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 10,615 | $1.41 | $14,962.90 |
DisclosureSEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted March 28, 2023. F4 · balance_after: Includes 33,559 restricted stock units. F6 · balance_after: Column 5 is being amended to reflect the correct amount of securities beneficially owned following reported transaction. Read SEC document |
| July 11, 2023 Filed Jan 23, 2024 22:00 UTC Amendment | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 1,057 | $3.84 | $4,054.76 |
DisclosureSEC source: 0001209191-24-002080 · doc4a.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Innovation Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,885 F1 · security: Late reporting of transaction being made as a result of an administrative oversight. F2 · kind: The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). F3 · price: This transaction was executed in multiple trades in prices ranging from $3.72 to $3.90, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. F4 · balance_after: Includes 33,559 restricted stock units. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,190 | $0.00 Strike: $5.11 | $0.00 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · derivative · entry 5 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,939 Underlying: Common Stock · 1,190 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from December 12, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · derivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,615 Underlying: Common Stock · 15,000 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 16,190 | $20.00 | $323,859.90 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.00 to $20.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 1,190 | $5.11 | $6,080.66 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,190 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2021 Filed Sep 15, 2021 22:35 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 15,000 | $1.41 | $21,144.00 |
DisclosureSEC source: 0001567619-21-017166 · doc1.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · derivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,615 Underlying: Common Stock · 15,000 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 2,184 | $21.72 | $47,440.85 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $21.665 to $21.85, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 12,816 | $21.45 | $274,883.98 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $20.67 to $21.66, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:47 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 15,000 | $1.41 | $21,144.00 |
DisclosureSEC source: 0001567619-21-011776 · doc1.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,175 | $0.00 Strike: $5.11 | $0.00 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · derivative · entry 7 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,129 Underlying: Common Stock · 1,175 shares Expires 2029-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from December 12, 2018 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $1.41 | $0.00 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · derivative · entry 6 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,615 Underlying: Common Stock · 15,000 shares Expires 2025-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to the option vest are fully vested and exercisable. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 237 | $29.96 | $7,100.52 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 5 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 5,680 | $29.21 | $165,913.94 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 4 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 237 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F3 · price: This transaction was executed in multiple trades in prices ranging from $28.92 to $29.86, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | SaleCommon Stock | 10,258 | $28.54 | $292,755.11 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 3 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,917 F1 · kind: The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan. F2 · price: This transaction was executed in multiple trades in prices ranging from $27.91 to $28.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 1,175 | $5.11 | $6,004.02 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 2 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,175 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2021 Filed Mar 29, 2021 21:10 UTC | Annexon, Inc. ANNX · Entity 5011 | Exercise / conversionCommon Stock | 15,000 | $1.41 | $21,144.00 |
DisclosureSEC source: 0001567619-21-007133 · doc1.xml · nonDerivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 25, 2021 Filed Mar 2, 2021 01:07 UTC | Annexon, Inc. ANNX · Entity 5011 | GrantStock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $30.07 | $0.00 |
DisclosureSEC source: 0001567619-21-005222 · doc1.xml · derivative · entry 1 Yednock Ted · CIK 0001818525 · EVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2031-02-25 F1 · derivative.exercise_date: 1/48th of the shares subject to the option vest on each monthly anniversary measured from February 25, 2021 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.